Stock BP8 BPH GLOBAL LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials BPH Global Ltd

Equities

BP8

AU0000284366

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 19:59:59 2024-05-22 EDT 		5-day change 1st Jan Change
0.001 AUD 0.00% Intraday chart for BPH Global Ltd 0.00% -33.33%
05-14 BPH Global Enters Term Sheet with Nutura Organic to Undertake Pilot Study in China MT
04-11 BPH Global Ltd. Announces Change of Registered Office CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 12.83 8.983 8.341 16.69 14.7 3.854
Enterprise Value (EV) 1 11.75 7.081 7.474 12.41 15.32 3.343
P/E ratio -3.25 x -3.31 x -5.91 x -4.45 x -3.98 x -0.72 x
Yield - - - - - -
Capitalization / Revenue 44.2 x 5.75 x 11.4 x 1.96 x 1.02 x 11,369 x
EV / Revenue 40.4 x 4.54 x 10.2 x 1.46 x 1.07 x 9,862 x
EV / EBITDA -6.51 x -4.65 x -5.17 x -6.56 x -5.56 x -1.36 x
EV / FCF -11.9 x -13.2 x -15.5 x -6.95 x -4.13 x 0.98 x
FCF Yield -8.38% -7.57% -6.45% -14.4% -24.2% 102%
Price to Book 10.7 x 5.32 x 18.9 x 3.01 x 4.83 x 200 x
Nbr of stocks (in thousands) 513,345 641,608 641,608 1,043,321 1,049,784 1,284,730
Reference price 2 0.0250 0.0140 0.0130 0.0160 0.0140 0.003000
Announcement Date 18-09-28 19-09-30 20-09-30 21-10-29 22-09-30 23-09-29
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.2907 1.561 0.7304 8.495 14.35 0.000339
EBITDA 1 -1.806 -1.523 -1.445 -1.891 -2.755 -2.453
EBIT 1 -1.908 -1.541 -1.464 -2.264 -2.882 -2.535
Operating Margin -656.39% -98.71% -200.49% -26.65% -20.08% -747,794.99%
Earnings before Tax (EBT) 1 -3.353 -2.267 -1.464 -2.537 -2.945 -4.047
Net income 1 -3.353 -2.266 -1.39 -2.814 -3.69 -4.828
Net margin -1,153.64% -145.11% -190.31% -33.12% -25.71% -1,424,179.35%
EPS 2 -0.007699 -0.004229 -0.002199 -0.003599 -0.003522 -0.004138
Free Cash Flow 1 -0.984 -0.5359 -0.482 -1.785 -3.714 3.421
FCF margin -338.52% -34.32% -66% -21.01% -25.88% 1,009,131.27%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-09-28 19-09-30 20-09-30 21-10-29 22-09-30 23-09-29
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 0.63 -
Net Cash position 1 1.09 1.9 0.87 4.28 - 0.51
Leverage (Debt/EBITDA) - - - - -0.2275 x -
Free Cash Flow 1 -0.98 -0.54 -0.48 -1.78 -3.71 3.42
ROE (net income / shareholders' equity) -202% -138% -103% -70.1% -52.6% -165%
ROA (Net income/ Total Assets) -56.6% -48% -53.1% -27.6% -21.4% -34.8%
Assets 1 5.926 4.72 2.615 10.18 17.26 13.86
Book Value Per Share 2 0 0 0 0.0100 0 0
Cash Flow per Share 2 0 0 0 0.0100 0 0
Capex 1 0.14 - - 0.45 0.89 0.15
Capex / Sales 47.35% - - 5.27% 6.19% 43,397.94%
Announcement Date 18-09-28 19-09-30 20-09-30 21-10-29 22-09-30 23-09-29
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BPH GLOBAL LTD Stock BPH Global Ltd
-33.33% 1.3M
MODERNA, INC. Stock Moderna, Inc.
+64.23% 62.59B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.31% 41.18B
LONZA GROUP AG Stock Lonza Group AG
+45.43% 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
-8.29% 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.97% 26.21B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.16% 19.09B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.54% 13.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.17% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.72% 12.26B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BP8 Stock
  4. Financials BPH Global Ltd